Industry steps up efforts to develop avian flu vaccineBMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7526.1164-c (Published 17 November 2005) Cite this as: BMJ 2005;331:1164
- John Zarocostas
Four prototype vaccines against avian flu in humans are expected to be submitted to regulatory authorities for approval before the end of 2006, industry representatives have said.
Dr Lee Jong-wook, director general of the World Health Organization, told a conference on avian and human influenza in Geneva last week: “A universal non-specific pandemic vaccine may be the ultimate protective solution for human influenza.”
However, the amount of flu vaccine that could be produced in the event of a pandemic outbreak is still difficult to estimate, because of the lack of results from clinical trials and the time lag from development …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial